Viridian Therapeutics, Inc.\DE (VRDN) Assets Average (2014 - 2026)

Viridian Therapeutics, Inc.\DE's Assets Average history runs 13 years deep, the most recent figure standing at $844.2 million for Q1 2026.

• On a quarterly basis, Assets Average rose 20.31% year-over-year to $844.2 million in Q1 2026; TTM through Mar 2026 was $844.2 million, a 20.31% increase from a year earlier, with the FY2025 full-year figure at $820.9 million, up 33.18% from the prior year.
• Assets Average grew to $844.2 million in Q1 2026 per VRDN's latest filing, from $738.3 million in the prior quarter.
• Across five years, Assets Average topped out at $844.2 million in Q1 2026 and bottomed at $176.5 million in Q2 2022.
• The 5-year median for Assets Average is $560.4 million (2024), against an average of $513.7 million.
• Across the five-year window, Assets Average jumped 112.4% in 2023 and fell 14.59% in 2025, its largest moves.
• Year by year, Assets Average stood at $437.8 million in 2022, then slipped by 6.45% to $409.6 million in 2023, then surged by 84.86% to $757.2 million in 2024, then slipped by 2.49% to $738.3 million in 2025, then rose by 14.35% to $844.2 million in 2026.
• Per Business Quant, the three latest VRDN Assets Average figures stand at $844.2 million (Q1 2026), $738.3 million (Q4 2025), and $579.7 million (Q3 2025).